Curevac N.V. buy MoneyMoney
Start price
10.12.23
/
0%
€5.11
Target price
10.12.24
€8.00
Performance (%)
-57.50%
Price
26.04.24
€2.17
Summary
This prediction is currently active. The BUY prediction by MoneyMoney for Curevac N.V. is performing very badly with a performance of -57.50%. This prediction currently runs until 10.12.24. The prediction end date can be changed by MoneyMoney at any time. This prediction was marked as speculative and is excluded from MoneyMoney's performance statistics.Performance without dividends (%)
Name | 1w | 1m |
---|---|---|
Curevac N.V. | 5.450% | 5.450% |
iShares Core DAX® | 2.594% | -1.158% |
iShares Nasdaq 100 | 3.553% | -1.727% |
iShares Nikkei 225® | 0.687% | -8.354% |
iShares S&P 500 | 2.209% | -0.942% |
According to MoneyMoney what are the pros and cons of Curevac N.V. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
ROE higher than 10% per year
Future proof or reliable business model
Revenue growth > 30% per year expected
High Investments for future growth
Stable Large shareholder and/or long term investor
Some uniques
EBIT growth > 30% per year expected
positive Cash Flow expected
Innovative
Market Leader or Top 3
Known brand
Capable Management
Good rating
Good culture
Cons
Increased challenges to pay loans and raise capital
Lower EBIT Margin than peer group
Higher risks for its business
Low dividend yield expected
Significant cyclical dependencies
Dependend from some customers or products
High valuation
Risky balance sheet
Growths slower than the competition
Comments by MoneyMoney for this prediction
In the thread Curevac N.V. diskutieren
Buy mit Kursziel 8,0
Stopped prediction by MoneyMoney for Curevac N.V.
Curevac N.V.
Start price
Target price
Perf. (%)
€40.50
27.11.21
27.11.21
€17.00
27.11.22
27.11.22
-81.97%
28.11.22
28.11.22
Could be worthwhile Investment >10% per year
ROE higher than 10% per year
Future proof or reliable business model
Increased challenges to pay loans and raise capital
Curevac N.V.
Start price
Target price
Perf. (%)
€42.80
21.09.20
21.09.20
€50.00
04.11.21
04.11.21
-16.45%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
ROE higher than 10% per year
Future proof or reliable business model
Increased challenges to pay loans and raise capital